Patient Profiles in HER2-Positive Breast Cancer - Episode 12

Patient Profile 1: Trastuzumab Deruxtecan for HER2+ Metastatic BC

, , ,

Expert perspectives on the use of trastuzumab deruxtecan in a patient with HER2+ metastatic breast cancer.

EP. 1: HER2+ Breast Cancer: Overview of the Treatment Armamentarium
EP. 2: Selecting and Sequencing Therapy for HER2+ Breast Cancer
EP. 3: Recent Trial Data in HER2+ Metastatic Breast Cancer
EP. 4: Patient Profile 1: Frontline Therapy for HER2+ mBC
EP. 5: Patient Profile 1: Second-Line Therapy for HER2+ mBC
EP. 6: Patient Profile 1: Sequencing Therapies in HER2+ mBC
EP. 7: Patient Profile 2: Patient with Triple-Positive mBC
EP. 8: Patient Profile 2: Second-Line Therapy for Triple-Positive mBC
EP. 9: Patient Profile 2: 3L Therapy for Triple-Positive mBC
EP. 10: Considering Novel Therapy for HER2+ Metastatic Breast Cancer
EP. 11: Patient Profile 1: 62-Year-Old Woman With Metastatic Breast Cancer
Now Viewing
EP. 12: Patient Profile 1: Trastuzumab Deruxtecan for HER2+ Metastatic BC
EP. 13: Patient Profile 2: 26-Year-Old Woman With Triple Positive Breast Cancer
EP. 14: Patient Profile 2: Strategies for Managing Brain Metastases in HER2+ Metastatic Breast Cancer
EP. 15: Patient Profile 2: How Should T-DM1 Be Sequenced in HER2+ mBC?
EP. 16: Patient Profile 2: Clinical Utility of the HER2CLIMB Regimen for HER2+ mBC
EP. 17: Patient Profile 2: Treatment Sequencing in a Patient with Progressive Brain Metastases
EP. 18: Patient Profile 3: 43-Year-Old Woman With Metastatic Breast Cancer Progressing Through Multiple Lines of Therapy
EP. 19: Patient Profile 3: Treatment Sequencing in a Patient with metastatic HER2+ Breast Cancer
EP. 20: Patient Profile 4: Strategies for Managing ILD in Patients Receiving Trastuzumab Deruxtecan
EP. 21: Patient Profile 4: Managing AEs in Patients Receiving Treatment for HER2+ BC
EP. 22: Patient Profile 5: Strategies for Managing Elevated Liver Function Tests in Patients on the HER2CLIMB Regimen
EP. 23: Future Directions in the Management of HER2+ Breast Cancer

Related Content:

Patient Profiles in HER2-Positive Breast CancerBreast Cancer
Tailor-Made for a Lifelong Pursuit of Precision in Cancer Care
Dr Sardesai on Lasofoxifene Plus Abemaciclib in ESR1-Mutant, ER+/HER2– Breast Cancer
Lasofoxifene Aims to Amplify Efficacy of Abemaciclib in ESR1-Mutated ER+/HER2– Metastatic Breast Cancer